The spread of antibiotic resistant bacteria is causing concern—and the call for new agents is getting louder and louder. But which antibiotics are needed most urgently? Today, for the first time, the
The human immunodeficiency virus has to overcome major obstacles to infect inactive immune cells. DZIF scientists have investigated the defence mechanism of these cells and found indications of a new
Since autumn 2015, the Zika virus epidemic has been causing marked increases in the birth of babies with much too small heads, or so-called “microcephaly”, especially in South and Central America. The
The spread of antibiotic-resistant bacteria is cause for concern–and no longer constitutes a problem that only hospitals face. In the current issue of Science, DZIF scientists from the University of
Researchers of the University of Tübingen and DZIF in collaboration with the biotech company Sanaria Inc. have demonstrated in a clinical trial that a new vaccine for malaria called Sanaria® PfSPZ
Almost everybody has it: Scientists estimate that approximately 98 percent of adults around the world are infected with the Epstein-Barr virus. In rare cases, an infection with this virus causes
Oumou Maiga-Ascofaré is currently working as a research fellow at the Bernhard Nocht Institute for Tropical Medicine in Hamburg and at the Kumasi Centre for Collaborative Research in Tropical Medicine
Severe malaria, caused by the Plasmodium falciparum parasite, causes dangerous circulatory disorders and neurological complications. If the affected person is not treated immediately, the disease will
Colistin is used as the “last-resort antibiotic” for dreaded multidrug-resistant pathogens, especially in hospitals. However, gut bacteria that have become insensitive to colistin now exist—owing to
An international team of scientists has sequenced the genomes of two rare malaria pathogens, both parasites of the plasmodium species. A scientist from the Bernhard Nocht Institute for Tropical
